A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study-Reference-Cited by-同舟云学术

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

Published:2001-04 Issue: Volume:37 Page:S285
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gluck S.,Crump M.,Stewart D.,Levine M.,Pritchard K.,Kirkbride P.,Dancey J.,O'Reilly S.,Shore T.,Couban S.,Girouard C.,Abuzara H.,Tu D.,Marlin S.,Shepherd L.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry;Bone Marrow Transplantation;2012-08-06

2. Breast cancer;Hematopoietic Stem Cell Transplantation in Clinical Practice;2009

3. Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000–2007;European Journal of Cancer;2008-10

4. Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16;Journal of Clinical Oncology;2008-01-01

5. Randomized Trial of Single Compared With Tandem High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in Patients With Chemotherapy-Sensitive Metastatic Breast Cancer;Journal of Clinical Oncology;2006-08-20